Intellectual Property

Trademark Notices

The absence of a product or service name or logo from this list does not constitute a waiver of Tandem Diabetes Care trademark or other intellectual property rights concerning that name or logo.

Patents in the United States

Patient-focused research and innovation is the backbone of Tandem Diabetes Care’s approach to improving the lives of people with diabetes. Our patents represent our commitment to developing unique and original products.

The t:slim, t:slim X2, t:slim G4, and/or t:flex insulin pumps are covered by the following U.S. patents. Additional patent applications pending in the United States and worldwide.

6,650,951
6,744,350
6,852,104
8,287,495
8,298,184
8,573,027
8,641,671
8,690,856
8,753,316
8,758,323
D980232
9,119,917
9,173,998
9,180,243
9,211,377
9,250,106
9,335,910
9,381,297
9,715,327
9,750,873
9,940,441
10,010,674
10,430,043
10,434,253
10,943,687
11,135,362
11,285,263
11,298,053
11,484,642
11,488,549
11,576,594

The t:connect mobile app is covered by the following patents in the United States. Additional patent applications pending in the United States and worldwide.

D864,217
D864,218
D864,219

The t:connect web application is covered by the following patents in the United States. Additional patent applications pending in the United States and worldwide.

10,541,987